Heart implant aims to replace blood thinners for stroke prevention
NCT ID NCT04684212
Summary
This study planned to test a small heart implant called the LAmbre Plus device in people with atrial fibrillation who are at risk of stroke. The device is designed to seal off a small pouch in the heart where clots often form, offering an alternative to taking daily blood-thinning pills. The trial was withdrawn before any patients were enrolled, so no results are available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Henry Ford Hospital
Detroit, Michigan, 48202, United States
Conditions
Explore the condition pages connected to this study.